StockData
Nkarta, Inc. logo

Nkarta, Inc. (NKTX) stock

NKTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30
$1.14+0.01 (+1.34%)

Close on Nov 20, 2026Market cap $81.29MP/E –Yield 0.00%

Nkarta shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Nkarta's shares outstanding was 74M at Jun 30, 2026. For fiscal 2025 it was 74M, up 9.0% from the year before. The highest annual figure on record is 74M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202574M+9.0%
FY2024Dec 31, 202468M+38.5%
FY2023Dec 31, 202349M+12.3%
FY2022Dec 31, 202244M+32.8%
FY2021Dec 31, 202133M+95.5%
FY2020Dec 31, 202017M+1049.1%
FY2019Dec 31, 20191M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 202674M+0.7%
Q1 FY2026Mar 31, 202674M+0.5%
Q4 FY2025Dec 31, 202574M+0.6%
Q3 FY2025Sep 30, 202574M+0.6%
Q2 FY2025Jun 30, 202574M+0.7%
Q1 FY2025Mar 31, 202574M+45.8%
Q4 FY2024Dec 31, 202474M+50.0%
Q3 FY2024Sep 30, 202474M+49.9%
Q2 FY2024Jun 30, 202473M+50.1%
Q1 FY2024Mar 31, 202451M+3.6%
Q4 FY2023Dec 31, 202349M+0.4%
Q3 FY2023Sep 30, 202349M+0.9%
Q2 FY2023Jun 30, 202349M+11.7%
Q1 FY2023Mar 31, 202349M+48.3%
Q4 FY2022Dec 31, 202249M+48.4%
Q3 FY2022Sep 30, 202249M+47.8%
Q2 FY2022Jun 30, 202244M+33.6%
Q1 FY2022Mar 31, 202233M+0.8%
Q4 FY2021Dec 31, 202133M+0.7%
Q3 FY2021Sep 30, 202133M+6.2%
Q2 FY2021Jun 30, 202133M+1832.7%
Q1 FY2021Mar 31, 202133M+1934.5%
Q4 FY2020Dec 31, 202033M+1965.6%
Q3 FY2020Sep 30, 202031M+1926.9%
Q2 FY2020Jun 30, 20202M+19.0%
Q1 FY2020Mar 31, 20202M–
Q4 FY2019Dec 31, 20192M–
Q3 FY2019Sep 30, 20192M–
Q2 FY2019Jun 30, 20191M–

More Nkarta figures

See a number that looks wrong?